51306-35-5 Usage
Description
5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE, also known as fluorescein derivative, is a synthetic compound with a unique chemical structure that exhibits strong fluorescence properties. It is characterized by the presence of a fluorescein molecule conjugated with a 4,6-dichloro-s-triazine moiety, which enhances its reactivity and specificity in various applications. 5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE is highly versatile and has found use in multiple industries due to its distinct fluorescent characteristics.
Uses
Used in Research and Diagnostic Applications:
5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE is used as a fluorescent reagent for the conjugation of fluorescein to proteins, carbohydrates, and selected polymers. This application is particularly useful in the field of life sciences, where it aids in the visualization, detection, and quantification of biomolecules, enabling researchers to study their structure, function, and interactions in detail.
Used in Biotechnology Industry:
In the biotechnology industry, 5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE is used as a labeling agent for various biological molecules. The strong fluorescence of this compound allows for the easy tracking and detection of labeled molecules in a variety of assays, such as enzyme-linked immunosorbent assays (ELISA), flow cytometry, and fluorescence microscopy. This enhances the efficiency and accuracy of these techniques, leading to improved research outcomes and diagnostic capabilities.
Used in Pharmaceutical Industry:
5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE is also utilized in the pharmaceutical industry for the development of drug candidates and the study of drug-biomarker interactions. 5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE's fluorescent properties enable researchers to monitor the distribution, metabolism, and excretion of drugs in the body, providing valuable insights into their pharmacokinetic and pharmacodynamic properties. This information is crucial for the optimization of drug formulations and the development of more effective therapeutic strategies.
Used in Environmental Monitoring:
In the field of environmental science, 5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE is employed as a tracer compound for monitoring the presence and movement of pollutants in aquatic ecosystems. 5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE's strong fluorescence allows for the sensitive detection of even trace amounts of contaminants, enabling researchers to assess the health of aquatic environments and develop strategies for pollution control and remediation.
Used in Material Science:
5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE is also used in material science for the development of advanced fluorescent materials and sensors. 5-(4,6-DICHLORO-S-TRIAZIN-2-YLAMINO)FLUORESCEIN-HYDROCHLORIDE's unique optical properties make it an attractive candidate for the creation of novel materials with enhanced sensing capabilities, such as those used in chemical and biological detection systems, as well as in the development of new imaging technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 51306-35-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,3,0 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 51306-35:
(7*5)+(6*1)+(5*3)+(4*0)+(3*6)+(2*3)+(1*5)=85
85 % 10 = 5
So 51306-35-5 is a valid CAS Registry Number.
InChI:InChI=1/C23H12Cl2N4O5.ClH/c24-20-27-21(25)29-22(28-20)26-10-1-4-14-13(7-10)19(32)34-23(14)15-5-2-11(30)8-17(15)33-18-9-12(31)3-6-16(18)23;/h1-9,30-31H,(H,26,27,28,29);1H
51306-35-5Relevant articles and documents
Single label comparative hybridization
-
, (2015/01/06)
The present invention provides methods of detecting and mapping chromosomal or genetic abnormalities associated with various diseases or with predisposition to various diseases, or to detecting the phenomena of large scale copy number variants. In particular, the present invention provides advanced methods of performing array-based comparative hybridization that allow reproducibility between samples and enhanced sensitivity by using the same detectable label for both test sample and reference sample nucleic acids. Invention methods are useful for the detection or diagnosis of particular disease conditions such as cancer, and detecting predisposition to cancer based on detection of chromosomal or genetic abnormalities and gene expression level. Invention methods are also useful for the detection or diagnosis of hereditary genetic disorders or predisposition thereto, especially in prenatal samples. Moreover, invention methods are also useful for the detection or diagnosis of de novo genetic aberrations associated with post-natal developmental abnormalities.
Assay for mycobacterium avium/intracellulare nucleic acid
-
, (2010/12/26)
Disclosed is a method for determining the presence of Mycobacterium avium complex nucleic acids in a biological sample. In particular, the mig gene of M. avium and the DT1 gene of M. intracellulare are detected, preferably following amplification. In addition, the method distinguishes between species of M. avium and M. intracellulare. Also described are oligonucleotides that can be used as primers to amplify target genes such as mig and DT1 genes and as probes as well as kits containing the oligonucleotides.
Activatable probes and methods for in vivo gene detection
-
, (2008/06/13)
Probes for detecting a target polynucleotide are provided. One aspect provides a molecular beacon probe set wherein the donor molecular beacon comprises a quantum dot and an acceptor molecular beacon comprises at least one reporter. The probes optionally comprise a protein transduction domain, targeting signal, or a combination thereof. Methods for detecting target polynucleotides using the disclosed probes are also provided.
